Igal Kushnir

Original Research

Safety and Efficacy of an Autologous Blood Clot Product in the Management of Texas 1A or 2A Neuropathic Diabetic Foot Ulcers: A Prospective, Multicenter, Open Label Pilot Study

07/02/2018

Robert J. Snyder

Maria A. Kasper

Keyur Patel

Marissa J. Carter

Igal Kushnir

Alon Kushnir

Thomas E. Serena

This pilot study evaluates safety in terms of the occurrence of adverse events (AEs) as well as the efficacy in terms of complete wound healing rates of a blood clot product when applied to chronic neuropathic diabetic foot ulcers (DFUs).

This pilot study evaluates...

07/02/2018

Wounds

Original Research

Efficacy and Safety of a Novel Autologous Wound Matrix in the Management of Complicated, Chronic Wounds: A Pilot Study

09/13/2016

Igal Kushnir

Alon Kushnir

Thomas E. Serena

Doron Garfinkel

09/13/2016

Wounds

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

February 2 ⁠–⁠ February 5

See Full Calendar

Igal Kushnir

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products